Viaderma Correlations
| VDRM Stock | USD 0.0004 0.00 0.00% |
The current 90-days correlation between Viaderma and Aoxing Pharmaceutical is 0.05 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Viaderma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Viaderma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Viaderma Correlation With Market
Poor diversification
The correlation between Viaderma and DJI is 0.79 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viaderma and DJI in the same portfolio, assuming nothing else is changed.
Viaderma |
The ability to find closely correlated positions to Viaderma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Viaderma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Viaderma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Viaderma to buy it.
Moving together with Viaderma Pink Sheet
| 0.74 | MKKGY | Merck KGaA ADR Earnings Call This Week | PairCorr |
| 0.63 | MKGAF | MERCK Kommanditgesells Earnings Call This Week | PairCorr |
| 0.88 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.8 | TKPHF | Takeda Pharmaceutical | PairCorr |
| 0.85 | HLN | Haleon plc | PairCorr |
| 0.82 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.86 | TEVA | Teva Pharma Industries | PairCorr |
| 0.82 | HLNCF | Haleon plc | PairCorr |
| 0.64 | HYMTF | Hyundai Motor | PairCorr |
| 0.87 | BIRDF | Bird Construction | PairCorr |
| 0.8 | GAM | General American Inv | PairCorr |
| 0.74 | PXMFF | Philex Mining | PairCorr |
| 0.61 | HFBA | HFB Financial Corp | PairCorr |
| 0.83 | QNBC | QNB Corp | PairCorr |
| 0.69 | EG | Everest Group | PairCorr |
| 0.7 | EDRVF | EDP Renovaveis | PairCorr |
| 0.68 | DAC | Danaos | PairCorr |
| 0.81 | SWGAY | Swatch Group AG | PairCorr |
| 0.62 | APPCF | APAC Resources | PairCorr |
| 0.85 | BHPLF | BHP Group Limited | PairCorr |
| 0.78 | PPCLY | PPC Ltd ADR | PairCorr |
| 0.84 | LIN | Linde plc Ordinary | PairCorr |
| 0.67 | RCIT | Reelcause | PairCorr |
| 0.84 | MARUY | Marubeni Corp ADR | PairCorr |
| 0.86 | SAPMF | Saipem SpA | PairCorr |
| 0.78 | ASTE | Astec Industries | PairCorr |
Moving against Viaderma Pink Sheet
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Viaderma Pink Sheet performing well and Viaderma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viaderma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| FFNTF | 30.04 | 7.17 | 0.13 | 0.49 | 20.91 | 0.00 | 1,091 | |||
| GSAC | 4.95 | 0.50 | 0.00 | 0.42 | 0.00 | 33.33 | 58.33 | |||
| PEMTF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PZOO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| RLBD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CWWBF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SFLM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GPFT | 9.14 | 0.73 | 0.03 | (0.69) | 10.18 | 20.00 | 66.67 | |||
| LRSV | 1.71 | (0.88) | 0.00 | 3.96 | 0.00 | 0.00 | 33.33 | |||
| AOXG | 12.06 | 3.72 | 0.11 | (0.76) | 10.80 | 33.33 | 127.17 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Viaderma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Viaderma Corporate Management
| Shaowen Zhang | Manager of Production | Profile | |
| Christopher Otiko | Chief Founder | Profile | |
| Baotang Zhao | Chief Sales Officer | Profile | |
| MPH MD | Medical Board | Profile |